Sort
10,766 grants matching “checkpoint inhibitor”
Genetically engineered mouse model to improve therapy of NUT carcinoma
$657,032Christopher A French · Brigham And Women'S Hospital · R01 · FY2025 · CA
Tumor and immune determinants of effective anti-tumor immunity in renal cell carcinoma
$656,848David Braun · Yale University · R37 · FY2023 · CA
Phase 1/2 Study of Modern Immunotherapy in BCG-Relapsing Urothelial Carcinoma of the Bladder - (ADAPT-BLADDER)
$656,816Noah M Hahn · Johns Hopkins University · R01 · FY2020 · CA
Phase 1/2 Study of Modern Immunotherapy in BCG-Relapsing Urothelial Carcinoma of the Bladder - (ADAPT-BLADDER)
$656,816Noah M Hahn · Johns Hopkins University · R01 · FY2019 · CA
Tumor Immune MicroEnvironment Facility (Scientific Core)
$656,518Wiem Lassoued · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA
Exploiting the VISTA Pathway to Prevent Acute GVHD and Control Steroid Refractory Disease
$656,304Bruce R. Blazar · University Of Minnesota · R01 · FY2024 · HL
Chemokine-mediated antigen-specific T cell responses and immunotherapies to treat head and neck cancer
$656,258Dohun Pyeon · Michigan State University · R01 · FY2023 · DE
POLQ Synthetic Lethality in HR-Deficient Pancreatic Adenocarcinoma
$656,180Diane M Simeone · New York University School Of Medicine · R01 · FY2023 · CA
A precision oncology approach to integrating of tumor microenvironment suppressive cell modulators to enhance antitumor immunity
$656,048Dung T Le · Johns Hopkins University · P01 · FY2023 · CA
Imaging tumor-associated macrophages in head and neck squamous cell carcinoma using fluorine-19 MRI
$655,700Eric T Ahrens · University Of California, San Diego · R01 · FY2024 · CA
Imaging tumor-associated macrophages in head and neck squamous cell carcinoma using fluorine-19 MRI
$655,698Eric T Ahrens · University Of California, San Diego · R01 · FY2025 · CA
Metallo-fluorocarbon nanoemulsion for PET detection of cancer inflammation
$655,698Eric T Ahrens · University Of California, San Diego · R01 · FY2023 · CA
Metallo-fluorocarbon nanoemulsion for PET detection of cancer inflammation
$655,698Eric T Ahrens · University Of California, San Diego · R01 · FY2025 · CA
Understanding efficacy and FE(II)-Promoted Activation of 1,2,4-Trioxolanes in cancer
$655,693Eric Collisson · Fred Hutchinson Cancer Center · R01 · FY2024 · CA
Targeting natural killer cells to enhance HIV vaccine responses
$655,652Stephen N. Waggoner · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · AI
Immunotherapy Modeling in Organoids Co-preserving Tumor and Infiltrating Immune Compartments
$655,548Calvin J Kuo · Stanford University · R01 · FY2025 · CA
Understanding and Overcoming Resistance to Cancer Immunotherapy Due to Defective Antigen Presentation
$655,529Katerina Abigail Politi · Yale University · R01 · FY2022 · CA
Proteolysis targeting chimera against nuclear receptor NR4A1 for melanoma therapy
$655,441Weizhou Zhang · University Of Florida · R01 · FY2025 · CA
Mechanistic connection between HPV-specific TCRs and therapeutic responses to ICI in HPV+ HNSCC
$655,244Jing Hong Wang · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Mechanistic connection between HPV-specific TCRs and therapeutic responses to ICI in HPV+ HNSCC
$655,244Jing Hong Wang · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
UBR5's mechanisms of action in tumorigenesis and immunoregulation
$655,228Xiaojing Ma · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
UBR5's mechanisms of action in tumorigenesis and immunoregulation
$655,228Xiaojing Ma · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
Tuning KITv CAR T cells for the solid tumor environment
$655,042Prasad S. Adusumilli · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Tuning KITv CAR T cells for the solid tumor environment
$655,042Prasad S. Adusumilli · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Investigating the Role of VISTA in Driving Immune Evasion in Acute Myeloid Leukemia
$654,837Li Lily Wang · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · CA